Summary

The Global Biocatalysts and Enzyme Engineering Market was valued at USD 3,181.31 million in 2025 and is projected to reach USD 5,631.87 million by 2035. The market is expected to expand at a CAGR of 5.88% during the forecast period, driven by increasing demand for sustainable and efficient bioprocessing solutions.

Growing Demand from the Pharmaceutical and Biopharmaceutical Industries Drives Market Growth
The expanding pharmaceutical and biopharmaceutical sectors are the primary drivers of the global biocatalysts and enzyme engineering market, as enzyme-based technologies enable the precise, efficient, and cost-effective production of complex drug molecules. Rising demand for biologics, gene therapies, and personalized medicines is further accelerating the adoption of advanced enzyme engineering solutions.

Market Segmentation Overview
By Product Type
• Enzymes: Widely used for efficient and precise biocatalytic reactions.
• Co-Enzyme: Supports enzyme activity in complex biochemical processes.
By Application
• Pharmaceutical Manufacturing: Enables cost-effective production of high-purity pharmaceutical compounds.
• Synthetic Biology and Metabolic Engineering: Facilitates engineered biological pathways for advanced bioprocesses.
• Diagnostic: Enhances accuracy and reliability of diagnostic testing methods.
• Others: Supports diverse industrial and research-based biological applications.
By End User
• Pharmaceutical and Biopharmaceutical Companies: Major adopters for innovative drug development processes.
• CROs and CDMOs: Offer specialized enzyme-based research and manufacturing services.
• Diagnostics and Clinical Laboratories: Utilize enzymes for accurate clinical testing applications.
• Others: Includes academic institutes and industrial research organizations.

Regional Analysis
North America and Europe lead the global biocatalysts and enzyme engineering market with strong research capabilities, established biotechnology industries, and advanced manufacturing infrastructure. Meanwhile, Asia Pacific is witnessing the fastest growth, while South America and the Middle East & Africa are steadily expanding through rising pharmaceutical investments and increasing adoption of sustainable bioprocessing technologies.

Strategic Collaboration for siRNA Manufacturing
March 2026 – CODEXIS: Codexis entered into a strategic agreement with an innovator pharmaceutical company to manufacture 50 grams of small interfering RNA (siRNA) using its proprietary ECO Synthesis platform. The collaboration supports preclinical development of a cardiovascular therapeutic candidate while reinforcing the company's leadership in scalable enzymatic manufacturing solutions.

Strategic Edge: Strengthening Innovation Through Academic Partnerships
Collaborations between biocatalyst companies and universities are creating significant opportunities to accelerate enzyme discovery and next-generation biocatalyst development. By leveraging advanced research expertise, specialized facilities, and scientific innovation, companies can develop high-performance enzyme solutions while reducing research costs and time-to-market.

Key Report Attributes
• Market Size 2025: USD 3,181.31 Million
• Market Size 2035: USD 5,631.87 Million
• CAGR (2025-2035): 5.88%
• Base Year: 2024
• Market Forecast Period: 2025-2035

Industry Segmentations Growth
• By Product Type: Enzymes - 6.04%, Co- Enzyme - 5.10%.
• By Application: Pharmaceutical Manufacturing - 5.44%, Synthetic Biology and Metabolic Engineering - 7.15%.
• By End User: Pharmaceutical and Biopharmaceutical Companies - 5.44%, CROs and CDMOs - 7.15%.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 17
2 MARKET INTRODUCTION 19
2.1 DEFINITION 19
2.2 SCOPE OF THE STUDY 19
2.3 RESEARCH OBJECTIVE 19
2.4 MARKET STRUCTURE 20
3 RESEARCH METHODOLOGY 21
3.1 OVERVIEW 21
3.2 DATA FLOW 23
3.2.1 DATA MINING PROCESS 23
3.3 PURCHASED DATABASE: 24
3.4 SECONDARY SOURCES: 25
3.4.1 SECONDARY RESEARCH DATA FLOW: 26
3.5 PRIMARY RESEARCH: 27
3.5.1 PRIMARY RESEARCH DATA FLOW: 28
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 29
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 30
3.6.1 REVENUE ANALYSIS APPROACH 30
3.7 DATA FORECASTING31
3.7.1 DATA FORECASTING TYPE 31
3.8 DATA MODELING 32
3.8.1 MICROECONOMIC FACTOR ANALYSIS: 32
3.8.2 DATA MODELING: 33
3.9 TEAMS AND ANALYST CONTRIBUTION 35
4 MARKET DYNAMICS 37
4.1 MARKET TRENDS IN GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING 37
4.1.1 SHIFT TOWARD GREEN AND SUSTAINABLE CHEMISTRY 37
4.1.2 ADVANCEMENTS IN ENZYME ENGINEERING TECHNOLOGIES 37
4.1.3 INCREASING USE IN PHARMACEUTICAL MANUFACTURING 37
4.2 DRIVERS 38
4.2.1 INCREASING DEMAND FOR GREEN TECHNOLOGIES 38
4.2.2 RISING HEALTHCARE COSTS 39
4.2.3 GROWING DEMAND FROM PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 39
4.3 RESTRAINTS 39
4.3.1 HIGH PRODUCTION COSTS 39
4.3.2 REGULATORY CHALLENGES 40
4.3.3 ENZYME STABILITY AND OPERATIONAL LIMITATIONS 40
4.4 OPPORTUNITIES 41
4.4.1 EXPANSION INTO EMERGING MARKETS 41
4.4.2 PARTNERSHIPS WITH ACADEMIC INSTITUTIONS 41
5 MARKET FACTOR ANALYSIS 43
5.1 PESTLE ANALYSIS 43
5.1.1 POLITICAL FACTORS 43
5.1.2 ECONOMIC FACTORS 43
5.1.3 SOCIAL FACTORS 43
5.1.4 TECHNOLOGICAL FACTORS 44
5.1.5 LEGAL FACTOR 44
5.1.6 ENVIRONMENTAL FACTORS 44
5.2 PORTER'S FIVE FORCES MODEL 45
5.2.1 THREAT OF NEW ENTRANTS 45
5.2.2 BARGAINING POWER OF SUPPLIERS 46
5.2.3 THREAT OF SUBSTITUTES 46
5.2.4 BARGAINING POWER OF BUYERS 46
5.2.5 INTENSITY OF RIVALRY 47
5.3 REGULATORY ENVIRONMENT & COMPLIANCE 47
5.3.1 OVERVIEW OF REGULATORY FRAMEWORK 47
5.3.2 PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS 47
5.4 TECHNOLOGICAL TRENDS 48
5.4.1 PROTEIN ENGINEERING AND DIRECTED EVOLUTION 48
5.4.2 SYNTHETIC BIOLOGY AND PATHWAY ENGINEERING48
5.5 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS 48
5.6 PARTNERSHIPS & COLLABORATIONS 49
5.6.1 ENZYME TECHNOLOGY ALLIANCE ADDS BIO-PRODICT 49
5.6.2 ACIES BIO AND PROTEIN EVOLUTION PARTNERSHIP 49
5.6.3 AMINOVERSE AND PROZOMIX STRATEGIC COLLABORATION 49
6 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE 51
6.1 OVERVIEW 51
6.2 ENZYME 53
6.2.1 KETOREDUCTASE 53
6.2.2 LACTATE DEHYDROGENASE 53
6.2.3 FORMATE DEHYDROGENASE 53
6.2.4 GLUCOSE DEHYDROGENASE 53
6.2.5 D-AMINO ACID DEHYDROGENASE 53
6.2.6 NITRO REDUCTASE 54
6.2.7 MONOAMINE OXIDASE 54
6.2.8 NITRILASE 54
6.2.9 AMIDASE 54
6.2.10 NITRILE REDUCTASE54
6.2.11 ALCOHOL OXIDASE 54
6.2.12 GALACTOSE OXIDASE 54
6.2.13 Ω-TRANSAMINASES (ATA) 54
6.2.14 ALDOLASE 55
6.2.15 PROTEASE 55
6.2.16 LIPASE 55
6.2.17 OTHERS 55
6.3 CO-ENZYMES 55
6.3.1 NAD⁺ / NADH 55
6.3.2 NADP⁺ / NADPH 56
6.3.3 NMN 56
6.3.4 FAD / FMN 56
6.3.5 OTHERS 56
7 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION 57
7.1 OVERVIEW 57
7.2 PHARMACEUTICALS MANUFACTURING 58
7.3 SYNTHETIC BIOLOGY AND METABOLIC ENGINEERING 58
7.4 DIAGNOSTIC 59
7.5 OTHERS 59
8 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER 61
8.1 OVERVIEW 61

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 34
TABLE 2 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 52
TABLE 3 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 57
TABLE 4 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019–2035 (USD MILLION) 62
TABLE 5 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY REGION, 2019-2035 (USD MILLION) 65
TABLE 6 NORTH AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 67
TABLE 7 NORTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 68
TABLE 8 NORTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 69
TABLE 9 NORTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 70
TABLE 10 US: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 70
TABLE 11 US: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 71
TABLE 12 US: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 72
TABLE 13 CANADA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 73
TABLE 14 CANADA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 74
TABLE 15 CANADA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 74
TABLE 16 EUROPE BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 76
TABLE 17 EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 77
TABLE 18 EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 78
TABLE 19 EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 79
TABLE 20 GERMANY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 79
TABLE 21 GERMANY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 80
TABLE 22 GERMANY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 81
TABLE 23 FRANCE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 81
TABLE 24 FRANCE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 82
TABLE 25 FRANCE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 82
TABLE 26 UK: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 83
TABLE 27 UK: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 84
TABLE 28 UK: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 84
TABLE 29 ITALY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 85
TABLE 30 ITALY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 86
TABLE 31 ITALY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 86
TABLE 32 SPAIN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 87
TABLE 33 SPAIN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 88
TABLE 34 SPAIN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 88
TABLE 35 RUSSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 89
TABLE 36 RUSSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 90
TABLE 37 RUSSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 90
TABLE 38 REST OF EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 91
TABLE 39 REST OF EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 92
TABLE 40 REST OF EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 92
TABLE 41 ASIA-PACIFIC BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 94
TABLE 42 ASIA PACIFIC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 95
TABLE 43 ASIA PACIFIC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 96
TABLE 44 ASIA PACIFIC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 96
TABLE 45 CHINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 97
TABLE 46 CHINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 98
TABLE 47 CHINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 98
TABLE 48 INDIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 99
TABLE 49 INDIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 100
TABLE 50 INDIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 100
TABLE 51 JAPAN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 101
TABLE 52 JAPAN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 102
TABLE 53 JAPAN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 102
TABLE 54 SOUTH KOREA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 103
TABLE 55 SOUTH KOREA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 104
TABLE 56 SOUTH KOREA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 104
TABLE 57 MALAYSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 105
TABLE 58 MALAYSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 106
TABLE 59 MALAYSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 106
TABLE 60 THAILAND: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 107
TABLE 61 THAILAND: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 108
TABLE 62 THAILAND: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 108
TABLE 63 INDONESIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 109
TABLE 64 INDONESIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 110
TABLE 65 INDONESIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 110
TABLE 66 REST OF APAC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 111
TABLE 67 REST OF APAC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 112
TABLE 68 REST OF APAC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 113
TABLE 69 LATIN AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 114
TABLE 70 SOUTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 115
TABLE 71 SOUTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 116
TABLE 72 SOUTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 116
TABLE 73 MEXICO: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 117
TABLE 74 MEXICO: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 118
TABLE 75 MEXICO: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 118
TABLE 76 BRAZIL: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 119
TABLE 77 BRAZIL: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 120
TABLE 78 BRAZIL: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 120
TABLE 79 ARGENTINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 121
TABLE 80 ARGENTINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 122
TABLE 81 ARGENTINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 122
TABLE 82 REST OF LATAM: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 123
TABLE 83 REST OF LATAM: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 124
TABLE 84 REST OF LATAM: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 124
TABLE 85 MIDDLE EAST & AFRICA BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 126
TABLE 86 MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 127
TABLE 87 MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 128
TABLE 88 MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 128
TABLE 89 GCC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 129
TABLE 90 GCC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 130
TABLE 91 GCC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 130
TABLE 92 SOUTH AFRICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 131
TABLE 93 SOUTH AFRICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 132
TABLE 94 SOUTH AFRICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 132
TABLE 95 REST OF MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 133
TABLE 96 REST OF MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 134
TABLE 97 REST OF MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 134
TABLE 98 EVALUATION 140
TABLE 99 NOVONESIS: PRODUCTS OFFERED 142
TABLE 100 CODEXIS INC.: PRODUCT OFFERED 147
TABLE 101 BIOCATALYSTS: PRODUCT OFFERED 150
TABLE 102 AMANO ENZYME INC.: PRODUCTS OFFERED 154
TABLE 103 INFINITA: PRODUCTS OFFERED 157
TABLE 105 CREATIVE ENZYMES: PRODUCTS OFFERED 165
TABLE 106 ASYMCHEM: PRODUCTS OFFERED 169
TABLE 108 ENGINZYME: PRODUCTS OFFERED 176LIST OF FIGURES
FIGURE 1 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET: STRUCTURE
FIGURE 2 GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2035) 38
FIGURE 3 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET
FIGURE 4 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY TYPE, SEGMENT ATTRACTIVENESS ANALYSIS
FIGURE 5 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY PRODUCT TYPE, 2025
FIGURE 6 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, ATTRACTIVENESS ANALYSIS
FIGURE 7 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY APPLICATION, 2024
FIGURE 8 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, ATTRACTIVENESS ANALYSIS
FIGURE 9 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY END USER, 2024
FIGURE 10 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY REGION, 2025
FIGURE 11 NORTH AMERICA MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION)
FIGURE 12 NORTH AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2025
FIGURE 13 EUROPE MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION)
FIGURE 14 EUROPE BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2025
FIGURE 15 ASIA-PACIFIC MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION)
FIGURE 16 ASIA-PACIFIC BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 17 LATIN AMERICA MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION)
FIGURE 18 LATIN AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 19 MIDDLE EAST & AFRICA MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 21 GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024
FIGURE 22 COMPETITOR DASHBOARD: GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET
FIGURE 23 NOVONESIS: SWOT ANALYSIS
FIGURE 24 BIOCATALYSTS LTD.: SWOT ANALYSIS
FIGURE 25 AMANO ENZYME INC.: SWOT ANALYSIS
FIGURE 26 ADVANCED ENZYMES: SWOT ANALYSIS
FIGURE 27 CREATIVE ENZYMES: SWOT ANALYSIS
FIGURE 28 ASYMCHEM: SWOT ANALYSIS
FIGURE 29 ALMAC: SWOT ANALYSIS